Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06462700 for aplastic anemia in Japanese participants
2021-002155-11Phase 3
- Sponsor
- Pfizer
- Start
- Jun 2021
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of antithymocyte globulin in aplastic anemia, sponsored by Pfizer. Primary endpoint: Hematologic response at week 12.
02
Drugs
antithymocyte globulin
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on 2021-002155-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002155-11.